[抗抑郁药治疗中的胺:一场革命?]
1Équipe « Contrôle-Interoception-Attention », Institut du Cerveau (ICM), Sorbonne Université, INSERM, CNRS, AP-HP, Hôpital de la Pitié-Salpêtrière, DMU Neurosciences, Paris, France - Service de Psychiatrie Adultes, GH de la Pitié Salpêtrière, 47-83 Bd de l'Hôpital, 75013 Paris, France.
胺提供治疗耐药性抑郁症 (TRD) 的快速抗抑郁作用. 它的机制涉及NMDA对抗,并影响乐观偏见,尽管长期的安全和滥用风险需要考虑.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
更多相关视频
10:32A Guide to In vivo Single-unit Recording from Optogenetically Identified Cortical Inhibitory Interneurons
Published on: November 7, 2014
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Electroconvulsive Therapy
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Parenteral Anesthetics: Overview
Antidepressant Drugs: Overview
